Unfractionated LMWH and the risk of HIT: are medical patients different?

被引:5
作者
Warkentin, TE [1 ]
Greinacher, A
机构
[1] McMaster Univ, Hamilton, ON L8S 4L8, Canada
[2] Univ Greifswald, D-17487 Greifswald, Germany
关键词
D O I
10.1182/blood-2005-08-3208
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
An advantage of low-molecular-weight heparin (LMWH) is its lower risk of heparin-induced thrombocytopenia (HIT) compared with unfractionated heparin (UFH). In this issue of Blood, Prandoni and colleagues question whether heparin-induced thrombocytopenia (HIT) is reduced by low-molecular-weight heparin (LMWH) in medical patients.
引用
收藏
页码:2931 / 2932
页数:2
相关论文
共 7 条
[1]   The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study [J].
Girolami, B ;
Prandoni, P ;
Stefani, PM ;
Tanduo, C ;
Sabbion, P ;
Eichler, P ;
Ramon, R ;
Baggio, G ;
Fabris, F ;
Girolami, A .
BLOOD, 2003, 101 (08) :2955-2959
[2]   Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy [J].
Greer, IA ;
Nelson-Piercy, C .
BLOOD, 2005, 106 (02) :401-407
[3]   Incidence and clinical relevance of heparin-induced antibodies in patients with deep vein thrombosis treated with unfractionated or low-molecular-weight heparin [J].
Lindhoff-Last, E ;
Nakov, R ;
Misselwitz, F ;
Breddin, HK ;
Bauersachs, R .
BRITISH JOURNAL OF HAEMATOLOGY, 2002, 118 (04) :1137-1142
[4]  
MARTEL N, 2005, BLOOD 0628
[5]   Heparin-induced thrombocytopenia in neurologic patients treated with low-molecular-weight heparin [J].
Pohl, C ;
Kredteck, A ;
Bastians, B ;
Hanfland, P ;
Klockgether, T ;
Harbrecht, U .
NEUROLOGY, 2005, 64 (07) :1285-1287
[6]   A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients [J].
Samama, MM ;
Cohen, AT ;
Darmon, JY ;
Desjardins, L ;
Eldor, A ;
Janbon, C ;
Leizorovicz, A ;
Nguyen, H ;
Olsson, CG ;
Turpie, AG ;
Weisslinger, N .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (11) :793-800
[7]   Heparin-induced thrombocytopenia: Recognition, treatment, and prevention [J].
Warkentin, TE ;
Greinacher, A .
CHEST, 2004, 126 (03) :311S-337S